Literature DB >> 8991768

[Lymphadenectomy in tumors of the upper gastrointestinal tract].

J R Siewert1, H J Stein, K Böttcher.   

Abstract

Similar to other tumor entities, complete tumor removal with an adequate safety margin in all three dimensions (the oral margin, the aboral margins and the tumor bed) must be the primary aim of any surgical approach to carcinoma of the upper gastrointestinal tract. The same goal has to be achieved in the area of the lymphatic drainage. All positive nodes and nodes with a so-called 'microinvolvement' have to be removed together with the primary tumor. The safety margin of lymphadenectomy can be estimated by the lymph node ratio, i.e., the ratio between the number of removed and positive nodes. Several studies have shown that for carcinoma of the upper gastrointestinal tract the prognosis can be improved markedly if the lymph node ratio is below 0.2. For tumors in the early phase of lymphatic metastasis this can be achieved by extensive lymph node dissection. In practice, this requires as a minimum a lymphadenectomy of compartments I and II of the tumor's lymphatic drainage (D2 lymphadenectomy). The individual compartments are determined by the embryogenesis of the affected organ and defined by the tumor location. In patients with advanced lymphatic metastases, lymphadenectomy does not improve the prognosis and can only result in a reduction of local recurrences. Lymphadenectomy does not increase the risk and morbidity of the surgical procedure, provided it is restricted to the removal of nodes. These basic principles of lymphadenectomy are valid for carcinomas of the esophagus, cardia and stomach.

Entities:  

Mesh:

Year:  1996        PMID: 8991768     DOI: 10.1007/pl00002535

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  4 in total

1.  Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.

Authors:  Alexander R Novotny; Christoph Schuhmacher; Raymonde Busch; Michael W Kattan; Murray F Brennan; Jörg Rüdiger Siewert
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 2.  Quality Management and Key Performance Indicators in Oncologic Esophageal Surgery.

Authors:  Ines Gockel; Constantin Johannes Ahlbrand; Michael Arras; Elke Maria Schreiber; Hauke Lang
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

Review 3.  [Oncologic esophageal resection and reconstruction : Open, hybrid, minimally invasive or robotic?]

Authors:  I Gockel; D Lorenz
Journal:  Chirurg       Date:  2017-06       Impact factor: 0.955

Review 4.  [Surgical strategy for early stage carcinoma of the esophagus].

Authors:  N Niclauss; M Chevallay; J L Frossard; S P Mönig
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.